ASML

1,206.6

+2.57%↑

SAP

147.78

-3.53%↓

IFX

38.48

+0.47%↑

NOKIA.FI

7.04

+2.33%↑

STMPA.FR

27.51

+1.89%↑

ASML

1,206.6

+2.57%↑

SAP

147.78

-3.53%↓

IFX

38.48

+0.47%↑

NOKIA.FI

7.04

+2.33%↑

STMPA.FR

27.51

+1.89%↑

ASML

1,206.6

+2.57%↑

SAP

147.78

-3.53%↓

IFX

38.48

+0.47%↑

NOKIA.FI

7.04

+2.33%↑

STMPA.FR

27.51

+1.89%↑

ASML

1,206.6

+2.57%↑

SAP

147.78

-3.53%↓

IFX

38.48

+0.47%↑

NOKIA.FI

7.04

+2.33%↑

STMPA.FR

27.51

+1.89%↑

ASML

1,206.6

+2.57%↑

SAP

147.78

-3.53%↓

IFX

38.48

+0.47%↑

NOKIA.FI

7.04

+2.33%↑

STMPA.FR

27.51

+1.89%↑

Search

Societe BIC SA

Chiusa

SettoreSettore delle tecnologie

52.3 0.97

Panoramica

Variazione del prezzo dell'azione

24h

Corrente

Minimo

51.2

Massimo

52.3

Metriche Chiave

By Trading Economics

Entrata

-66M

9.8M

Vendite

-64M

1B

P/E

Media del settore

12.813

77.27

Rendimento da dividendi

4.42

Margine di Profitto

0.963

Dipendenti

13,000

EBITDA

-190M

-17M

Raccomandazioni

By TipRanks

Raccomandazioni

Neutrale

Previsioni per 12 mesi

+0.39% upside

Dividendi

By Dow Jones

Rendimento da dividendi

Media del settore

4.42%

2.29%

Utili prossimi

28 apr 2026

Statistiche di mercato

By TradingEconomics

Capitalizzazione di Mercato

-142M

2.2B

Apertura precedente

51.33

Chiusura precedente

52.3

Notizie sul Sentiment di mercato

By Acuity

25%

75%

65 / 376 Classifica in Technology

Punteggio Tecnico

By Trading Central

Fiducia

Bearish Evidence

Societe BIC SA Grafico

Le prestazioni passate non sono un indicatore affidabile dei risultati futuri.

Notizie correlate

23 mar 2026, 23:47 UTC

Acquisizioni, Fusioni, Takeovers

Gilead Sciences to Buy Ouro Medicines, Collaborate With Galapagos on Purchased Assets -- Update

23 mar 2026, 22:55 UTC

Acquisizioni, Fusioni, Takeovers

Gilead Sciences to Buy Ouro Medicines for Up to $2.18 Billion

23 mar 2026, 21:51 UTC

Acquisizioni, Fusioni, Takeovers

Italy's Postal Service Makes $12.50 Billion Bid for Telecom Italia -- 3rd Update

23 mar 2026, 23:59 UTC

Discorsi di Mercato

Global Equities Roundup: Market Talk

23 mar 2026, 23:59 UTC

Discorsi di Mercato

Woodside, Santos Earnings Power Up on Surging LNG Prices -- Market Talk

23 mar 2026, 23:50 UTC

Discorsi di Mercato

Nikkei May Rise on Hopes for U.S. Talks With Iran -- Market Talk

23 mar 2026, 23:37 UTC

Discorsi di Mercato

Gold Rises, Boosted by Fall in Dollar, U.S. Treasury Yields -- Market Talk

23 mar 2026, 22:42 UTC

Discorsi di Mercato
Principali Notizie su Eventi

Global Equities Roundup: Market Talk

23 mar 2026, 22:42 UTC

Discorsi di Mercato
Principali Notizie su Eventi

Bell Potter Names Miners Less Exposed to Fuel Price, Supply Risks -- Market Talk

23 mar 2026, 22:40 UTC

Acquisizioni, Fusioni, Takeovers

Gilead Sciences to Buy Ouro Medicines for Up to $2.18B

23 mar 2026, 22:23 UTC

Discorsi di Mercato

Apollo Debt Solutions Shrugs Off Private-Credit Fears -- Market Talk

23 mar 2026, 22:22 UTC

Acquisizioni, Fusioni, Takeovers

Gilead Sciences: OM336 Is for Treatment of Autoantibodies Driven Immune-Mediated Disease

23 mar 2026, 22:21 UTC

Acquisizioni, Fusioni, Takeovers

Gilead Sciences: Company Would Pay Galapagos Royalties of 20%-23% of Net OM336 Sales

23 mar 2026, 22:21 UTC

Acquisizioni, Fusioni, Takeovers

Gilead Sciences: Company Would Retain Sole Worldwide Commercialization Rights of OM336 Outside of Greater China

23 mar 2026, 22:20 UTC

Acquisizioni, Fusioni, Takeovers

Gilead Sciences: Company, Galapagos Would Collaborate on Development of OM336 >GILD

23 mar 2026, 22:20 UTC

Acquisizioni, Fusioni, Takeovers

Gilead Sciences: Galapagos Would Absorb Substantially All of Ouro's Operating Assets, Retain Its Employees >GILD

23 mar 2026, 22:19 UTC

Acquisizioni, Fusioni, Takeovers

Gilead Sciences: Galapagos Would Pay 50% of Upfront Consideration and 50% of Any Contingent Milestone Payments Payable to Ouro Shareholders

23 mar 2026, 22:19 UTC

Acquisizioni, Fusioni, Takeovers

Gilead Sciences: Currently in Advanced Discussions With Galapagos With Respect to Potential Research-and-Development Collaboration on Acquired Ouro Assets

23 mar 2026, 22:18 UTC

Acquisizioni, Fusioni, Takeovers

Gilead Sciences to Buy Ouro Medicines for About $1.68B Upfront, Up to $500M in Contingent Milestone Payments >GILD

23 mar 2026, 22:15 UTC

Acquisizioni, Fusioni, Takeovers

Gilead Sciences To Acquire Ouro Medicines To Advance First In Class T Cell Engager Program For Autoimmune Diseases >GILD

23 mar 2026, 22:08 UTC

Discorsi di Mercato

Ebos Needs to Reset Its Gearing Targets -- Market Talk

23 mar 2026, 21:42 UTC

Discorsi di Mercato

Global Forex and Fixed Income Roundup: Market Talk

23 mar 2026, 21:42 UTC

Discorsi di Mercato

RBNZ's Breman Strikes Reassuring Tone On Rates -- Market Talk

23 mar 2026, 21:32 UTC

Utili

WuXi XDC Cayman: Results Aided by Strong Growth in Contract Research, Development and Manufacturing Organisation Business>2268.HK

23 mar 2026, 21:32 UTC

Utili

WuXi XDC Cayman 2025 Net CNY1.56B Vs. Net CNY917.16M >2268.HK

23 mar 2026, 21:32 UTC

Utili

WuXi XDC Cayman 2025 Rev CNY5.94B Vs. CNY4.05B >2268.HK

23 mar 2026, 21:10 UTC

Principali Notizie su Eventi

Oil Is Back Under $100. Trump Says Iran Has Agreed to No Nuclear Weapons. -- Barrons.com

23 mar 2026, 20:50 UTC

Discorsi di Mercato

Tech, Media & Telecom Roundup: Market Talk

23 mar 2026, 20:50 UTC

Discorsi di Mercato

Health Care Roundup: Market Talk

23 mar 2026, 20:50 UTC

Discorsi di Mercato
Utili
Principali Notizie su Eventi

Basic Materials Roundup: Market Talk

Confronto tra pari

Modifica del prezzo

Societe BIC SA Previsione

Obiettivo di Prezzo

By TipRanks

0.39% in crescita

Previsioni per 12 mesi

Media 52 EUR  0.39%

Alto 53 EUR

Basso 51 EUR

Basato su 2 analisti di Wall Street che offrono Obiettivi di Prezzo a 12 mesi per Societe BIC SA - Dist negli ultimi 3 mesi.

Consenso sulla valutazione

By TipRanks

Neutrale

2 ratings

0

Acquista

2

Mantieni

0

Vendi

Punteggio Tecnico

By Trading Central

55.4 / 57.1Supporto e resistenza

A breve termine

Bearish Evidence

A termine intermedio

Bearish Evidence

A lungo termine

Strong Bearish Evidence

Sentiment

By Acuity

65 / 376 Classifica in Settore delle tecnologie

Notizie sul Sentiment di mercato

Prove rialziste molto forti

Volatilità

Sotto la media

Volume delle notizie (RCV)

Sotto la media

Notizie finanziarie

Spese di vendita e di amministrazione

Spese operative

Utile prima delle imposte

Vendite

Costo delle vendite

Utile lordo sulle vendite

Interessi passivi sul debito

EBITDA

Utile operativo

$

Chi Siamo Societe BIC SA

Société BIC SA manufactures and sells stationery, lighter, shaver, and other products worldwide. It offers ball and coloring felt pens, glitter pens, markers, graphic and coloring pencils, shavers, mechanical pencils, sticky notes, printing products, stationery dyes, leads, white boards, correction tapes; pocket, utility, and decorated lighters; paints, gouache, watercolor, gels, highlighters, and various other products. The company also provides refillable shavers, permanent and temporary tattoo markers, semi permanent tattoo, and smart reusable notebooks, kits, crafting accessories, modeling clay and slime, refills, razor for men and women, and razor cartridges. In addition, it sells batteries and shaving preps; and advertising and promotional products. Further, the company is involved in the provision of delivery services; production of industrial equipment; manufacture and sale of blades; and manufacture and distribution of IT solutions and consumer products, as well as insurance activities. It markets its products primarily under the BIC, BIC Kids, Cello, Lucky, RocketBook, Tipp-Ex, BIC Wite-Out, Tattly, ami, DJEEP, InkBox, BIC Soleil, BIC Evolution, BodyMark, and other brands through a range of channels, including retail mass-market distributors, traditional stores, and office product suppliers, as well as an e-commerce site. The company was founded in 1944 and is headquartered in Clichy, France.
help-icon Live chat